go back

Kentucky rates for HCPCS C9073

Brexucabtagene autoleucel, up to 200 million autologous anti-CD19 CAR positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $52,481 · 10th–90th $38,905–$63,0960%20%10th90th$52,481Professionalmedian $51,286 · 10th–90th $46,774–$380,1890%20%40%10th90th$51,286$50.0K$100.0K$200.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample — interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
CareSource
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$38,904.51 / $52,480.75 / $63,095.73
CareSource
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$46,773.51 / $51,286.14 / $380,189.40